Grosvenor Holdings’s CalciMedica CALC Stock Holding History

Grosvenor Holdings’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15,461	Closed	-$1.2M	–	22
2021 Q1	$1.2M	Buy	+15,461	New	+$4.63M	0.09%	22

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

JJIJ

Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return

Grosvenor Holdings's CALC Position: Q2 2021 in Review

Grosvenor Holdings sold out of CalciMedica (CALC) in Q2 2021, closing a stake of 15,461 shares — an estimated $1.2M sold.

Grosvenor Holdings first reported a position in CALC in Q1 2021 and held it in 1 quarter. The position peaked at $1.2M in Q1 2021. 41 funds tracked by Wall St. Rank hold CALC as of Q2 2021.

Grosvenor Holdings reported no remaining CalciMedica position as of Q2 2021 after selling out during the quarter.
Grosvenor Holdings sold 15,461 CalciMedica shares in Q2 2021, an estimated $1.2M.
Grosvenor Holdings first reported a position in CalciMedica in Q1 2021 and held it in 1 quarter.
Grosvenor Holdings's CalciMedica position peaked at $1.2M in Q1 2021.
41 funds tracked by Wall St. Rank held CalciMedica as of Q2 2021.

Based on Grosvenor Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.